Only four genes differentially expressed in both LGG and GBM patients (ERBB1, RB1, ESR1, and KDR), indicating putative role in the regulatory of circadian rhythm pathway alteration in glioma. This evidence concerns the gene ESR1 and central nervous system cancer.